Presentation Information
[1P-875]Evaluation of MSCs as vehicles for oncolytic viruses and the influence of their tissue sources on anti-tumor efficacy.
○Makoto Sukegawa1,2,3, Yoshitaka Miyagawa1, Yoshiyuki Yamazaki1, Seiji Kuroda1, Motoko Yamamoto1, Kumi Adachi1, Nobuhiko Taniai2, Hiroshi Yoshida3, Akihiro Umezawa4, Mashito Sakai1, Takashi Okada5 (1. Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan, 2. Department of Gastrointestinal Surgery, Nippon Medical School Musashikosugi Hospital, Kawasaki, Japan, 3. Department of Surgery, Nippon Medical School, Tokyo, Japan, 4. Center for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan, 5. Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in